Skip to main content
Journal of Neurosurgery: Case Lessons logoLink to Journal of Neurosurgery: Case Lessons
. 2021 Jun 21;1(25):CASE21175. doi: 10.3171/CASE21175

Primary microcystic/reticular schwannoma of the frontal bone: illustrative case

Xuemiao Zhao 1, Xinmu Zhou 2, Xiao Chen 1, Junqiao Pan 1, Bingrong Li 1,
PMCID: PMC9245779  PMID: 35855082

Abstract

BACKGROUND

To the best of the authors’ knowledge, this is the first case of microcystic/reticular schwannoma arising in the frontal bone.

OBSERVATIONS

An 18-year-old man presented to the authors’ orthopedic clinic with a complaint of a progressively enlarging, painless mass in the frontal bone. It showed significant hyperintensity on T2-weighted imaging with progressive enhancement. Computed tomography combined with three-dimensional reconstruction showed expansive bone destruction with a soft tissue mass in the left side of the frontal bone, without calcification inside or a sclerotic margin around it. The mass was a microcystic/reticular schwannoma as confirmed by surgical pathology.

LESSONS

The authors report a rare case of a microcystic/reticular schwannoma arising in the frontal bone, with relatively comprehensive imaging data that enabled them to learn more about this tumor.

Keywords: schwannoma, tomography, computer tomography, magnetic resonance imaging, case report

ABBREVIATIONS : CA = carbohydrate antigen, CT = computed tomography, MRI = magnetic resonance imaging, T1WI = T1-weighted imaging, T2WI = T2-weighted imaging


A rare type of schwannoma, microcystic/reticular schwannoma was first reported in 2008.1 In the present case, we had comprehensive clinical and multiple imaging data, which led us to learn more about microcystic/reticular schwannoma.

Illustrative Case

History

An 18-year-old man who was a resident of Lishui City, a state in southeastern China, presented to our orthopedic outpatient clinic for the first time in January 2020 with a history of a progressively enlarging, painless mass in the left frontal bone that had first been discovered by accident 1 year earlier. On palpation, a painless and poorly mobile mass, about 2 cm in length, was found in the left forehead, with no skin ulceration. The patient underwent his first contrast-enhanced magnetic resonance imaging (MRI) study the next day, and the mass was reported as an eosinophilic granuloma. However, the patient came to the hospital again in July because of further enlargement of the lesion. On the day of his presentation, physical examination and computed tomography (CT) showed that the left forehead mass was about 4 to 5 cm in length. Finally, the mass was resected approximately a week later and confirmed as a microcystic/reticular schwannoma.

Laboratory tests, including 7 tumor markers (α-fetoprotein, carcinoembryonic antigen, prostate-specific antigen, carbohydrate antigen [CA] 19-9, CA50, CA242, neuron-specific enolase), blood and urine routine tests, liver and kidney function tests, hepatitis virus tests, and Treponema pallidum and human immunodeficiency virus detection, revealed no positive findings.

Imaging Findings

Contrast-enhanced MRI performed in January 2020 showed a clean boundary mass in the left frontal bone, measuring about 2.7 × 3.4 × 2.8 cm in size. The lesion showed relative hypointensity on T1-weighted imaging (T1WI) compared with white matter (Fig. 1A), significant hyperintensity on T2-weighted imaging (T2WI) (Fig. 1B), relative hyperintensity on fluid-attenuated inversion recovery imaging (Fig. 1C), and a high apparent diffusion coefficient value (Fig. 1D). In contrast-enhanced sequences, the lesion showed mild heterogeneous enhancement on the axial images (Fig. 2A) and progressive enhancement on combined sagittal and coronal images (Fig. 2B and C).

FIG. 1.

FIG. 1.

A clean boundary mass in the left frontal bone, measuring about 2.7 × 3.4 × 2.8 cm in size, showed hypointensity on T1WI (A) and hyperintensity on T2WI (B) and fluid-attenuated inversion recovery (C), which indicated that the lesion contained abundant water, while the high apparent diffusion coefficient value indicated unlimited diffusion (D).

FIG. 2.

FIG. 2.

The lesion showed heterogeneous mild to moderate enhancement with small flakes of relatively significant enhancement (arrow in A) on the axial image, sagittal image (B), and a large area of obvious enhancement on the coronal image (C).

CT performed in July 2020 demonstrated that bone destruction was present in the left frontal bone, without a sclerosing edge or obvious calcification (Fig. 3D), nearing which the cortex was incomplete (Fig. 3A).

FIG. 3.

FIG. 3.

The local bone cortex was interrupted incompletely (arrow in A), the edge was irregular (arrow in D), and there was no sclerotic edge or calcification in the lesion throughout axial (A and B), sagittal (C), and coronal (D) images.

Operation and Pathology

The operation revealed a soft frontal bone mass closely adherent to the endocranium (Fig. 4). Grossly, the lesion was incompletely encapsulated and locally invaded adjacent bone cortex, the cut surface of which was grayish yellow and jelly-like, measuring about 4.0 × 4.0 × 2.5 cm in size (Fig. 5A). Microscopic examination showed the spindle-shaped tumor cells had no obvious atypia and rare mitosis, arranging in a reticular, microcapsule-like structure within obvious mucinous degenerative stroma (Fig. 5B).

FIG. 4.

FIG. 4.

General specimen of the operation. The margin was skull, and the center was tumor.

FIG. 5.

FIG. 5.

A: The section of the specimen (one-quarter) showed that the mass was grayish-yellow and jelly like. B: The tumor cells were arranged in a reticular, microcapsule-like structure with mucinous stroma. Hematoxylin and eosin stain, original magnification ×100. C: S100 staining was strongly positive. S100 stain, original magnification ×100.

Immunohistochemistry revealed the following: vimentin+, S100+, SOX-10+, CR+, glial fibrillary acidic protein negative, CD117−, CD34−, ETS-related gene positive, CD31+, podoplanin negative, desmin negative, smooth muscle actin positive (locally positive), AE1/AE3−, epithelial membrane antigen negative, and Ki-67+ (about 5%) (Fig. 5C). The final diagnosis was microcystic/reticular schwannoma.

Discussion

Observations

MRI showed that the lesion was water rich, without diffusion limitation on diffusion-weighted imaging, and accompanied by progressive filling enhancement. CT showed that the lesion had an irregular border but no sclerotic edge, and the corresponding cranial plate became thin, even discontinuous. Combined CT and MRI revealed that the lesion enlarged significantly in 6 months. All of these observations were sufficiently important that they contributed to a preoperative diagnosis. Microcystic/reticular neurinoma is rare; 36 cases had been reported globally as of January 2021 (only 28 cases in 17 articles in PubMed). It is extremely rare in bone (2 cases in total).2–10 To the best of our knowledge, the imaging findings described in this article have not been reported before.

Lessons

Before surgery was performed, the radiologists raised several possibilities. First, the lesion was deemed to be a water-/blood-rich disease according to its hyperintensity on T2WI, so that eosinophilic granuloma, lamellar meningioma, and lymphoma were excluded because their signal is similar to that of soft tissue.11,12 Second, although chondrogenic tumors, particularly those with mucus, might show significant hyperintensity on T2WI, they were hardly seen in the skull. Moreover, no calcification was seen on CT, which was another reason that a cartilage origin was unsupported. Regarding angiogenic tumors, the “gradually filling” enhancement was ample evidence (because the enhancement area of the lesion was enlarged throughout the axial, sagittal, and coronal images, among which there was a certain time interval; this was a reasonable speculation based on insufficient images and also an experience of imaging analysis). Nonetheless, this diagnosis was finally excluded because the enhancement in the arterial phase was far from a sufficient distinction. Unfortunately, we failed to make a definitive diagnosis. As a conclusion, our final inclination was a gelatinous or mucinous malignancy.

Most microcapsule/reticular schwannomas have an infiltrating growth pattern; therefore, resection is necessary. Differing from other malignant schwannomas, it had a favorable prognosis, and there has been no report of recurrence or metastasis.1

Acknowledgments

We extend thanks to Prof. Enfen Shu and Ming Luo for suggestions and help.

Disclosures

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Author Contributions

Acquisition of data: Zhou, Chen, Pan. Analysis and interpretation of data: Zhou, Pan. Drafting the article: Li, Zhao. Critically revising the article: Zhao. Reviewed submitted version of manuscript: Li, Zhao. Approved the final version of the manuscript on behalf of all authors: Li.

References

  • 1. Liegl B, Bennett MW, Fletcher CDM. Microcystic/reticular schwannoma: a distinct variant with predilection for visceral locations. Am J Surg Pathol. 2008;32(7):1080–1087. doi: 10.1097/PAS.0b013e318160cfda. [DOI] [PubMed] [Google Scholar]
  • 2. Tang SX, Sun YH, Zhou XR, Wang J. Bowel mesentery (meso-appendix) microcystic/reticular schwannoma: case report and literature review. World J Gastroenterol. 2014;20(5):1371–1376. doi: 10.3748/wjg.v20.i5.1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Trivedi A, Ligato S. Microcystic/reticular schwannoma of the proximal sigmoid colon: case report with review of literature. Arch Pathol Lab Med. 2013;137(2):284–288. doi: 10.5858/arpa.2011-0386-CR. [DOI] [PubMed] [Google Scholar]
  • 4. Kienemund J, Liegl B, Siebert F, et al. Microcystic reticular schwannoma of the colon. Endoscopy. 2010;42(suppl 2):E247. doi: 10.1055/s-0030-1255606. [DOI] [PubMed] [Google Scholar]
  • 5. Gu MJ, Choi JH. Microcystic/reticular schwannoma of the esophagus: the first case report and a diagnostic pitfall. BMC Gastroenterol. 2014;14(1):193. doi: 10.1186/s12876-014-0193-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Liegl B, Bodo K, Martin D, et al. Microcystic/reticular schwannoma of the pancreas: a potential diagnostic pitfall. Pathol Int. 2011;61(2):88–92. doi: 10.1111/j.1440-1827.2010.02614.x. [DOI] [PubMed] [Google Scholar]
  • 7. Bedir R, Semerci O, Fındık Güvendi G. Incidental cutaneous microcystic/reticular schwannoma in pilonidal sinus. Balkan Med J. 2019;37(1):52–53. doi: 10.4274/balkanmedj.galenos.2019.2019.7.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Georgescu TA, Dumitru AV, Oproiu AM, et al. Cutaneous microcystic/reticular schwannoma: case report and literature review of an exceedingly rare entity with an unusual presentation. Rom J Morphol Embryol. 2018;59(1):303–309. [PubMed] [Google Scholar]
  • 9. Yin Y, Wang T, Cai YP, et al. Microcystic/reticular schwannoma of the mandible first case report and review of the literature. Medicine (Baltimore) 2015;94(45):e1974. doi: 10.1097/MD.0000000000001974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Liu C, Yan L, Liu Q, et al. Lumbar intraspinal microcystic/reticular schwannoma: case report and literature review. Medicine (Baltimore) 2018;97(39):e12474. doi: 10.1097/MD.0000000000012474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Guo R, Xu P, Cheng S, et al. Comparison of nasopharyngeal MR, 18F-FDG PET/CT, and 18F-FDG PET/MR for local detection of natural killer/T-cell lymphoma, nasal type. Front Oncol. 2020;10:576409. doi: 10.3389/fonc.2020.576409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Woertler K. Benign bone tumors and tumor-like lesions: value of cross-sectional imaging. Eur Radiol. 2003;13(8):1820–1835. doi: 10.1007/s00330-003-1902-z. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurosurgery: Case Lessons are provided here courtesy of American Association of Neurological Surgeons

RESOURCES